Back to the main directory
Press Release
- USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis by GlobeNewsWire
- Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland by GlobeNewsWire
- Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million by GlobeNewsWire
- EQS-News: Cenkos Securities sees combination of factors behind M&A slowdown by EQS Group AG
- Farmers National Bank Announces Appointment of Chief Operating Officer by BusinessWire
- X4 Pharmaceuticals Prices $65.0 Million Public Offering by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Biffa plc by EQS Group AG
- ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: HomeServe plc by EQS Group AG
- STMicroelectronics augmente les performances et l’autonomie des véhicules électriques avec ses nouveaux modules de puissance en carbure de silicium by GlobeNewsWire
- Avis d’ajustement des droits des titulaires d’OCEANEs Vertes by GlobeNewsWire
- Menninger & Associates Financial Planning Joins LPL Financial by GlobeNewsWire
- Fortinet Secure SD-WAN Delivers 300% ROI Over Three Years and Payback in Eight Months, New Independent Study Finds by GlobeNewsWire
- Shineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval for Its In-situ Fecal Specimen Sampling Device by GlobeNewsWire
- PLBY Group Amends Credit Agreement to Enhance Covenant Flexibility by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc by EQS Group AG
- ESKER : Programme de rachat d'actions et Contrat de liquidité by GlobeNewsWire
- Despite Inflation and Recession Fears, U.S. Homeowners Continued to Invest in Their Homes in 2022 by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc by EQS Group AG
- The audit committee's opinion on the transaction with the related parties by GlobeNewsWire
- Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administration Regarding QN-302 for the Treatment of G4-Targeted Advanced Solid Tumors by GlobeNewsWire
- EQS-News: Mondia: Personnalisation dans les médias : l’aide des technologies (par Paolo Rizzardini) by EQS Group AG